HBK Investments L P Acquires Shares of 441,651 The Cooper Companies, Inc. $COO

HBK Investments L P bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 441,651 shares of the medical device company’s stock, valued at approximately $31,666,000. HBK Investments L P owned approximately 0.23% of Cooper Companies as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Sequoia Financial Advisors LLC grew its holdings in shares of Cooper Companies by 290.4% in the second quarter. Sequoia Financial Advisors LLC now owns 34,286 shares of the medical device company’s stock valued at $2,459,000 after acquiring an additional 25,504 shares in the last quarter. Tidal Investments LLC lifted its holdings in Cooper Companies by 281.4% during the second quarter. Tidal Investments LLC now owns 82,903 shares of the medical device company’s stock worth $5,945,000 after acquiring an additional 61,165 shares during the period. National Pension Service boosted its position in Cooper Companies by 9,314.0% in the second quarter. National Pension Service now owns 526,149 shares of the medical device company’s stock worth $37,730,000 after purchasing an additional 520,560 shares during the last quarter. WINTON GROUP Ltd grew its stake in Cooper Companies by 379.0% in the 2nd quarter. WINTON GROUP Ltd now owns 42,483 shares of the medical device company’s stock valued at $3,046,000 after purchasing an additional 33,613 shares during the period. Finally, Engineers Gate Manager LP grew its stake in Cooper Companies by 8,637.7% in the 2nd quarter. Engineers Gate Manager LP now owns 249,897 shares of the medical device company’s stock valued at $17,920,000 after purchasing an additional 247,037 shares during the period. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Trending Headlines about Cooper Companies

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Three directors made substantial purchases after the selloff: Paul Keel bought 4,701 shares, Lawrence Kurzius bought 10,000 shares and Walter Rosebrough Jr. purchased 10,000 shares across two transactions. The combined buying of approximately $1.33 million may signal that insiders view COO’s valuation as attractive after the decline. Insider purchase report
• Positive Sentiment: The company’s previously announced $3 billion share-repurchase authorization, potentially covering up to 22.7% of outstanding shares, could provide support if management follows through. Third-quarter adjusted EPS of $1.15 also exceeded the $1.12 consensus estimate. Cooper Companies financial information
• Negative Sentiment: Revenue was approximately $1.07 billion, below the roughly $1.10 billion analyst expectation. Cooper also reduced its full-year outlook, with adjusted EPS now projected at $4.51–$4.55 and revenue at $4.23–$4.25 billion, reflecting slower contact-lens demand and continuing U.S. channel inventory reductions at CooperVision. Levi and Korsinsky investor notice
• Negative Sentiment: Analyst sentiment has deteriorated: the reported consensus price target was reduced 14.83% to $72.27, while several firms downgraded COO or lowered their ratings following the results. This reinforces investor concerns that the earnings slowdown may persist. Consensus price target report
• Negative Sentiment: Several law firms, including Bragar Eagel & Squire, Levi & Korsinsky and Kirby McInerney, announced investigations into potential securities-law claims involving Cooper Companies. The investigations do not establish wrongdoing, but they add legal, reputational and headline risk while the stock is near its one-year low. Bragar Eagel and Squire investigation

Cooper Companies Stock Performance

NASDAQ COO traded up $1.34 on Wednesday, hitting $54.61. 5,314,057 shares of the stock traded hands, compared to its average volume of 2,517,650. The business’s fifty day moving average is $70.88 and its two-hundred day moving average is $69.19. The Cooper Companies, Inc. has a 12 month low of $51.01 and a 12 month high of $89.83. The firm has a market capitalization of $10.38 billion, a price-to-earnings ratio of 18.64, a PEG ratio of 2.21 and a beta of 0.82. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.73 and a current ratio of 1.22.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Wednesday, September 9th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.12 by $0.03. Cooper Companies had a return on equity of 10.90% and a net margin of 13.46%.The firm had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.10 billion. During the same period in the previous year, the company posted $0.49 earnings per share. The business’s revenue was up .5% on a year-over-year basis. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. As a group, equities analysts anticipate that The Cooper Companies, Inc. will post 4.53 EPS for the current fiscal year.

Cooper Companies declared that its board has authorized a share repurchase plan on Wednesday, September 9th that allows the company to repurchase $3.00 billion in shares. This repurchase authorization allows the medical device company to purchase up to 22.7% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s management believes its shares are undervalued.

Insider Buying and Selling

In other Cooper Companies news, Director Lawrence Kurzius bought 10,000 shares of the business’s stock in a transaction on Monday, September 14th. The stock was purchased at an average price of $53.91 per share, for a total transaction of $539,100.00. Following the completion of the transaction, the director directly owned 21,099 shares of the company’s stock, valued at $1,137,447.09. This trade represents a 90.10% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Paul A. Keel bought 4,701 shares of Cooper Companies stock in a transaction dated Friday, September 11th. The stock was acquired at an average price of $53.18 per share, with a total value of $249,999.18. Following the purchase, the director directly owned 4,701 shares of the company’s stock, valued at approximately $249,999.18. This represents a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders bought 24,701 shares of company stock valued at $1,330,739. 2.08% of the stock is owned by insiders.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Piper Sandler lowered Cooper Companies from an “overweight” rating to a “neutral” rating and decreased their target price for the company from $86.00 to $59.00 in a research report on Thursday, September 10th. The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a report on Wednesday, May 27th. Mizuho set a $75.00 price target on shares of Cooper Companies and gave the company an “outperform” rating in a research report on Thursday, September 10th. Stifel Nicolaus set a $70.00 price objective on shares of Cooper Companies and gave the stock a “buy” rating in a report on Thursday, September 10th. Finally, BNP Paribas Exane decreased their price objective on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a report on Monday, June 8th. Five investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, Cooper Companies presently has an average rating of “Hold” and an average price target of $71.47.

Cooper Companies Profile

Cooper Companies, Inc is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company develops, manufactures and markets products through two primary business segments: CooperVision and CooperSurgical.

CooperVision specializes in contact lenses, including daily disposable, toric, multifocal, multifocal toric, specialty and myopia-management lenses. Its products are designed to address a range of vision-correction needs, including astigmatism, presbyopia and irregular corneas.